Showing results (5221-5230 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|May 30, 2017
Tissue Engineered Skin and Wound Healing: Current Strategies and Future DirectionsNandana Bhardwaj, Dimple Chouhan, Biman B MandalCurrent Pharmaceutical Design|September 9, 2016
Phage Display Derived IgNAR V Region Binding Domains for Therapeutic DevelopmentObinna C Ubah, Caroline J Barelle, Magdalena J Buschhaus, et al.Current Pharmaceutical Design|October 8, 2021
Organic- or Inorganic-based Nanomaterials: Opportunities and Challenges in the Selection for BiomedicinesRanjith K KankalaCurrent Pharmaceutical Design|February 25, 2022
Recent Advances in the Surfactant and Controlled Release Polymer-based Solid DispersionAman Gupta, Gourav Paudwal, Rigzin Dolkar, et al.Current Pharmaceutical Design|July 28, 2022
An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic AspectsMaryam Jamshidnia, Robert D E Sewell, Mahmoud Rafieian-KopaeiCurrent Pharmaceutical Design|February 14, 2022
Long Non-Coding RNAs and Obesity: New Potential Pathogenic BiomarkersMartina Fontanini, Manuela Cabiati, Manuel Giacomarra, et al.Current Pharmaceutical Design|September 23, 2021
Headache in Multiple Sclerosis - Pharmacological AspectsMarcel Gebhardt, Peter Kropp, Frank Hoffmann, et al.Current Pharmaceutical Design|January 28, 2022
Potential Effects of Exosomes and their MicroRNA Carrier on OsteoporosisQi-Cheng Li, Ci Li, Wei Zhang, et al.Current Pharmaceutical Design|July 15, 2022
Therapeutic Potential of P2X7 Purinergic Receptor Modulation in the Main Organs Affected by the COVID-19 Cytokine StormJúlia Leão Batista Simões, Leilane Dayane Sobierai, Stefany Maciel Pereira, et al.Current Pharmaceutical Design|July 15, 2022
Withdrawn: A Review of Current Evidence from Cardiovascular Manifestations and Outcomes in Patients with COVID-19Shirin Saberianpour, Elahe Aleebrahim-Dehkordi, Elaheh Mazaheri, et al.Pageof 1,008